1. Sudha T, Teja V, Gopal M, Rajesh M, Lakshmi V. Comparative evaluation of TRI‐DOT rapid HIV test with fourth‐generation ELISA for the detection of human immunodeficiency virus. Clin Microbiol Infect. 2005;11(10):850-2.
2. Metcalf JA, Davey R, Lane HC. Acquired immunodeficiency syndrome: serologic and virologic tests. In: Devita VT, Curran J, HellmanELL S, et al. eds. AIDS: etiology, diagnosis, treatment and prevention. 4th ed. Philadelphia: Lippincott-Raven; 1997. pp. 177-96.
3. Brust S, Duttmann H, Feldner J, Gürtler L, Thorstensson R, Simon F. Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test. J Virol Methods. 2000; 90(2):153-65.
4. Cohen PT, Sande MA, Volberding PA, Gold J. The AIDS knowledge base. J Acquir Immune Defic Syndr. 1991; 4(8):831.
5. Constantine NT, van der Groen G, Belsey EM, Tamashiro H. Sensitivity of HIV-antibody assays determined by seroconversion panels. AIDS. 1994; 8(12):1715-20.
6. Feinberg MB. Changing the natural history of HIV disease. Lancet. 1996; 348(9022):239-46.
7. Saville RD, Constantine NT, Cleghorn FR, Jack N, Bartholomew C, Edwards J, et al. Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody. J Clin Microbiol. 2001; 39(7):2518-24.
8. Meyer KB, Pauker SG. Screening for HIV: can we afford the false positive rate? N Engl J Med. 1987; 317(4):238-41.
9. Schito ML, D'Souza MP, Owen SM, Busch MP. Challenges for rapid molecular HIV diagnostics. J Infect Dis. 2010; 201(Supplement 1):S1-S6.
10. Wright RJ, Stringer JS. Rapid testing strategies for HIV-1 serodiagnosis in high-prevalence African settings. Am J Prev Med. 2004; 27(1):42-8.
11. Control CfD, Prevention. Laboratory testing for the diagnosis of HIV infection: updated recommendations. Published June. 2014;27 .
12. WHO Organization, Guidelines for use in HIV testing and counselling services in resource-constrained settings. Geneva; WHO Organization: 2004.
13. Mbewu A, Simelela N, Makubalo L. Operational plan for comprehensive HIV and AIDS care, management and treatment for South Africa. Pretoria: Department of Health. 2003.
14. Gouya M. National report on HIV and AIDS cases. Tehran, Iran: Disease Management Center, Ministry of Health and Medical Education Tehran; 2009.
15. Haukoos JS, White DA, Lyons MS, Hopkins E, Calderon Y, Kalish B, et al. Operational methods of HIV testing in emergency departments: a systematic review. Ann Emerg Med. 2011; 58(1):S96-S103.
16. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus Type 1 infection. N Engl JMed. 1991; 324(14):961-4.
17. Mardani M. HIV/AIDS good news and bad news. Arch Clin Infect Dis. 2014; 9(4):e26541.
18. Mehra B, Bhattar S, Bhalla P, Rawat D. Rapid tests versus ELISA for screening of HIV infection: Our experience from a voluntary counselling and testing facility of a tertiary care centre in north India. Isrn Aids. 2014; 2014.
19. Torane V, Shastri J. Comparison of ELISA and rapid screening tests for the diagnosis of HIV, Hepatitis B and Hepatitis C among healthy blood donors in a tertiary care hospital in Mumbai. Indian J Med Microbiol. 2008; 26(3):284-5.
20. Kheirandish P, Seyedalinaghi S, Hosseini M, Jahani M, Shirzad H, Foroughi M, et al. Prevalence and correlates of HIV infection among male injection drug users in detention in Tehran, Iran. J Acquir Immune Defic Syndr. 2010; 53(2):273-5.
21. Zamani S, Kihara M, Gouya MM, Vazirian M, Ono-Kihara M, Razzaghi EM, et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS. 2005; 19(7):709-16.
22. Louie B, Wong E, Klausner JD, Liska S, Hecht F, Dowling T, et al. Assessment of rapid tests for detection of human immunodeficiency virus-specific antibodies in recently infected individuals. J Clin Microbiol. 2008; 46(4):1494-7.